Hormone withdrawal-associated symptoms with ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 µg/desogestrel 150 µg (21/7 regimen)

Johannes Bitzer,1 Maria Jesusa Banal-Silao,2 Hans-Joachim Ahrendt,3 Jaime Restrepo,4 Marion Hardtke,5 Ulrike Wissinger-Graefenhahn,6 Dietmar Trummer7 1Department of Obstetrics and Gynecology, University Hospital of Basel, Basel, Switzerland; 2University of the Philippines College of Medicine, Manila...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Bitzer J, Banal-Silao MJ, Ahrendt HJ, Restrepo J, Hardtke M, Wissinger-Graefenhahn U, Trummer D
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Dove Medical Press 2015-05-01
Schriftenreihe:	International Journal of Women's Health
Online-Zugang:	http://www.dovepress.com/hormone-withdrawal-associated-symptoms-with-ethinylestradiol-20-microg-peer-reviewed-article-IJWH
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!